ArticleJournal of bone oncology2022

A phase IB and randomised phase IIA trial of CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases: CARBON trial results.

Matthew Winter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.